Deepika Pakianathan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deepika pakianathan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deepika Pakianathan Today - Breaking & Trending Today

Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report published on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Shares of Calithera Biosciences stock opened at $0.04 on Thursday. The firm has a fifty day moving average of $0.06 and a […] ....

Deepika Pakianathan , Calithera Biosciences , Capital Management Group , Calithera Biosciences Inc , Vanguard Group Inc , Securities Exchange Commission , Renaissance Technologies , Alyeska Investment Group , Goldman Sachs Group Inc , Get Rating , Director Deepika Pakianathan , Exchange Commission , Management Group , Sachs Group , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Calithera Biosciences stock opened at $0.04 on Thursday. Calithera Biosciences has a twelve month low of $0.04 and a twelve month […] ....

Deepika Pakianathan , Calithera Biosciences , Capital Management Group , Calithera Biosciences Inc , Goldman Sachs Group Inc , Affinity Asset Advisors , Alyeska Investment Group , Renaissance Technologies , Calithera Biosciences Company Profile , Get Rating , Director Deepika Pakianathan , Sachs Group , Management Group , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research note issued to investors on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance NASDAQ:CALA opened at $0.05 on Tuesday. The company has a 50-day moving average of $0.09 and a 200-day moving […] ....

Calithera Biosciences , Deepika Pakianathan , Securities Exchange Commission , Renaissance Technologies , Goldman Sachs Group Inc , Affinity Asset Advisors , Alyeska Investment Group , Capital Management Group , Calithera Biosciences Inc , Get Rating , Director Deepika Pakianathan , Exchange Commission , Sachs Group , Management Group , Glutaminase Inhibitor , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research report sent to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Down 27.1 % Shares of CALA opened at $0.04 on Monday. The stock has a fifty day simple moving […] ....

Calithera Biosciences , Deepika Pakianathan , Vanguard Group Inc , Affinity Asset Advisors , Renaissance Technologies , Goldman Sachs Group Inc , Calithera Biosciences Company Profile , Calithera Biosciences Inc , Alyeska Investment Group , Get Rating , Biosciences Stock Down , Director Deepika Pakianathan , Asset Advisors , Sachs Group , Vanguard Group , Glutaminase Inhibitor , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Rating) in a research report report published on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance CALA stock opened at $0.06 on Monday. The stock has a market capitalization of $267,850.00, a P/E ratio of 0.00 […] ....

Calithera Biosciences , Deepika Pakianathan , Capital Management Group , Alyeska Investment Group , Calithera Biosciences Company Profile , Renaissance Technologies , Affinity Asset Advisors , Calithera Biosciences Inc , Securities Exchange Commission , Goldman Sachs Group Inc , Get Rating , Director Deepika Pakianathan , Exchange Commission , Asset Advisors , Sachs Group , Management Group , Glutaminase Inhibitor , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,